Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers

NCT02198326 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBN 4096 BS- in single rising doses
DRUG: Placebo

Sponsor

Boehringer Ingelheim